£0.75
0.86%
London, Dec 24, 01:35 pm CET
ISIN
GB00BL6NGV24
Symbol
DOCS

Dr Martens Stock price

£0.75
+0.02 2.94% 1M
+0.02 2.76% 6M
+0.05 7.62% YTD
+0.03 4.79% 1Y
-0.89 54.18% 3Y
-3.23 81.09% 5Y
-3.23 81.09% 10Y
-3.23 81.09% 20Y
London, Closing price Wed, Dec 24 2025
-0.01 0.86%
ISIN
GB00BL6NGV24
Symbol
DOCS

New AI Insights on Dr Martens Insights AI Insights on Dr Martens

How does the company make money?
Who are the company’s main competitors?
What are the key opportunities and risks?
How is the company managed?

Key metrics

Basic
Market capitalization
£727.2m
Enterprise Value
£1.0b
Net debt
£299.2m
Cash
£95.7m
Shares outstanding
966.4m
Valuation (TTM | estimate)
P/E
37.6 | 18.1
P/S
0.9 | 0.9
EV/Sales
1.3 | 1.3
EV/FCF
7.3
P/B
2.2
Dividends
DPS
£0.02
Yield 1Y | 5Y
2.5% | 1.5%
Growth 1Y | 5Y
-68.5% | -
Payout 1Y | 3Y
- | 67.6%
Increased
0 Years
Financials (TTM | estimate)
Revenue
£785.0m | £810.0m
EBITDA
£175.3m | £156.6m
EBIT
£105.1m | £81.7m
Net Income
£15.3m | £40.3m
Free Cash Flow
£139.8m
Growth (TTM | estimate)
Revenue
-2.6% | 2.9%
EBITDA
15.6% | 10.0%
EBIT
30.6% | 16.8%
Net Income
-48.0% | 794.7%
Free Cash Flow
-31.4%
Margin (TTM | estimate)
Gross
65.5%
EBITDA
22.3% | 19.3%
EBIT
13.4%
Net
2.0% | 5.0%
Free Cash Flow
17.8%
Financial Health
Equity Ratio
41.2%
Return on Equity
1.2%
ROCE
15.4%
ROIC
9.5%
Debt/Equity
1.2
More
EPS
£0.0
FCF per Share
£0.1
Short interest
-
Employees
2k
Rev per Employee
£340.0k
Show more

Is Dr Martens a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,079 stocks worldwide.

Dr Martens Stock Analysis

Unlock Scores for Free

Analyst Opinions

10 Analysts have issued a Dr Martens forecast:

6x Buy
60%
4x Hold
40%

Analyst Opinions

10 Analysts have issued a Dr Martens forecast:

Buy
60%
Hold
40%

Financial data from Dr Martens

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '25
+/-
%
785 785
3% 3%
100%
- Direct Costs 271 271
3% 3%
34%
514 514
3% 3%
66%
- Selling and Administrative Expenses 339 339
10% 10%
43%
- Research and Development Expense - -
-
-
175 175
16% 16%
22%
- Depreciation and Amortization 70 70
1% 1%
9%
EBIT (Operating Income) EBIT 105 105
31% 31%
13%
Net Profit 15 15
48% 48%
2%

In millions GBP.

Don't miss a Thing! We will send you all news about Dr Martens directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Dr. Martens Plc engages in the manufacture and sale of footwear products. The firm offers boots, shoes, sandals, shoe care products, laces, and socks. It operates through the following geographical segments: EMEA, Americas, and APAC. The company was founded by Klaus Maertens in 1945 and is headquartered in London, the United Kingdom.

Head office United Kingdom
CEO Ije Nwokorie
Employees 2,348
Founded 1945
Website www.drmartensplc.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today